Showing results (81-90 of 696) with videos related to
Sort By:
Pageof 70
Plos One|September 7, 2013
Progranulin is a novel independent predictor of disease progression and overall survival in chronic lymphocytic leukemiaMaria Göbel, Lewin Eisele, Michael Möllmann, et al.Blood|July 10, 2025
A noncoding mutation in the NOTCH1 gene initiates oncogenic NOTCH signaling via wild-type NICD stabilization in CLLMin Guo, Tugba Memis, Alena Sophie Ehrmann, et al.Oncology Research and Treatment|February 19, 2016
Genomic Features: Impact on Pathogenesis and Treatment of Chronic Lymphocytic LeukemiaEugen Tausch, Daniel Mertens, Stephan StilgenbauerFrontiers in Oncology|February 1, 2021
Telomere Dysfunction in Chronic Lymphocytic LeukemiaBilly Michael Chelliah Jebaraj, Stephan StilgenbauerOncology Research and Treatment|April 17, 2015
Obinutuzumab (GA101) for the treatment of chronic lymphocytic leukemia and other B-cell non-hodgkin's lymphomas: a glycoengineered type II CD20 antibodyValentin Goede, Christian Klein, Stephan StilgenbauerHematology. American Society of Hematology. Education Program|December 7, 2024
Risk-stratification in frontline CLL therapy: standard of careEugen Tausch, Christof Schneider, Stephan StilgenbauerF1000Prime Reports|August 29, 2014
Advances in treating chronic lymphocytic leukemiaEugen Tausch, Daniel Mertens, Stephan StilgenbauerExpert Opinion on Pharmacotherapy|November 22, 2011
Treating chronic lymphocytic leukemia with thalidomide and lenalidomideKrzysztof Giannopoulos, Daniel Mertens, Stephan StilgenbauerClinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Immunoglobulin heavy chain variable gene usage and (super)-antigen drive in chronic lymphocytic leukemiaAndreas Bühler, Thorsten Zenz, Stephan StilgenbauerBlood Cancer Discovery|December 12, 2025
Overcoming BTK Inhibitor Resistance in Chronic Lymphocytic Leukemia by Targeting PKCβBilly Michael Chelliah Jebaraj, Stephan StilgenbauerPageof 70